Analysts downgraded uniQure N.V. after the U.S. Food and Drug Administration signalled it would require a sham surgery-controlled Phase 3 trial for the company’s Huntington’s disease therapy, dimming ...

An international, randomized, double-blind, placebo-controlled Phase III study—the largest of its kind for mpox—found that tecovirimat did not improve clinical outcomes for adults with clade II mpox ...

When Elise Felicione tried to design a clinical trial for a supplement, 5 things got in the way. It’s a lesson for the ...

Their makers claim they can detect dozens of cancer types — but some scientists say they could be missing many cancers or ...

Bioavailability data recently obtained from Phase 1 study with a stable crystal form of neflamapimod manufactured using a new ...

A novel GLP-1 receptor agonist (RA) pill called orforglipron leads to a larger reduction in blood sugar levels after a year ...

Despite a trend toward more patient-centered research, quality-of-life end points remain substantially underreported in phase ...

Antipsychotic medicines are a key part of the pharmacological treatment of schizophrenia. Although they provide therapeutic ...

Intellia said the FDA removed the clinical hold on application for the Phase 3 clinical trial of nexiguran ziclumeran. The study is a randomized, double-blind, placebo-controlled trial evaluating the ...

This week Mad in America examines three studies around art therapy and art-based interventions for mental health issues. Two studies reported on the lived Studies find art-based interventions can be ...

AMT-130 Huntington’s gene therapy data, FDA Phase III sham-trial push, cash runway, and 2026 catalysts—read now.

"Disappointing" trial results, but some researchers remain hopeful ...